Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

FREMONT, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today anno.

Continue

Do you trust this headline?

Based on recent headline ratings, 84% of this readership currently trusts the local media, which has an average score of 83% regionally and is currently trending negative.

84%

Media Trust Score

Read All

In

News